| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc2b03342511abc88f60c63f2acd96d0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 |
| filingDate |
2004-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e68aff79c5cd46607d34a18eacdbabde |
| publicationDate |
2004-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004186055-A1 |
| titleOfInvention |
PsiepsilonRACK peptide composition and method for protection against tissue damage due to ischemia |
| abstract |
A method of reducing damage to cells and tissue caused by an ischemic or hypoxic event is disclosed. The method includes administering to the cell or tissue, either in vivo or ex vivo, ψεRACK peptide. The peptide can be administered before, during or after the ischemic or hypoxic event. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009062208-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010286050-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010048482-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7741290-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007299012-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009186814-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8426364-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006148700-A1 |
| priorityDate |
2000-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |